Investigating interventions in Alzheimer's disease with computer simulation models.

Progress in the development of therapeutic interventions to treat or slow the progression of Alzheimer's disease has been hampered by lack of efficacy and unforeseen side effects in human clinical trials. This setback highlights the need for new approaches for pre-clinical testing of possible i...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Carole J Proctor, Delphine Boche, Douglas A Gray, James A R Nicoll
Formato: article
Lenguaje:EN
Publicado: Public Library of Science (PLoS) 2013
Materias:
R
Q
Acceso en línea:https://doaj.org/article/8caadb27d5ab41cb97fdeff47d23c4c2
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
id oai:doaj.org-article:8caadb27d5ab41cb97fdeff47d23c4c2
record_format dspace
spelling oai:doaj.org-article:8caadb27d5ab41cb97fdeff47d23c4c22021-11-18T08:54:59ZInvestigating interventions in Alzheimer's disease with computer simulation models.1932-620310.1371/journal.pone.0073631https://doaj.org/article/8caadb27d5ab41cb97fdeff47d23c4c22013-01-01T00:00:00Zhttps://www.ncbi.nlm.nih.gov/pmc/articles/pmid/24098635/?tool=EBIhttps://doaj.org/toc/1932-6203Progress in the development of therapeutic interventions to treat or slow the progression of Alzheimer's disease has been hampered by lack of efficacy and unforeseen side effects in human clinical trials. This setback highlights the need for new approaches for pre-clinical testing of possible interventions. Systems modelling is becoming increasingly recognised as a valuable tool for investigating molecular and cellular mechanisms involved in ageing and age-related diseases. However, there is still a lack of awareness of modelling approaches in many areas of biomedical research. We previously developed a stochastic computer model to examine some of the key pathways involved in the aggregation of amyloid-beta (Aβ) and the micro-tubular binding protein tau. Here we show how we extended this model to include the main processes involved in passive and active immunisation against Aβ and then demonstrate the effects of this intervention on soluble Aβ, plaques, phosphorylated tau and tangles. The model predicts that immunisation leads to clearance of plaques but only results in small reductions in levels of soluble Aβ, phosphorylated tau and tangles. The behaviour of this model is supported by neuropathological observations in Alzheimer patients immunised against Aβ. Since, soluble Aβ, phosphorylated tau and tangles more closely correlate with cognitive decline than plaques, our model suggests that immunotherapy against Aβ may not be effective unless it is performed very early in the disease process or combined with other therapies.Carole J ProctorDelphine BocheDouglas A GrayJames A R NicollPublic Library of Science (PLoS)articleMedicineRScienceQENPLoS ONE, Vol 8, Iss 9, p e73631 (2013)
institution DOAJ
collection DOAJ
language EN
topic Medicine
R
Science
Q
spellingShingle Medicine
R
Science
Q
Carole J Proctor
Delphine Boche
Douglas A Gray
James A R Nicoll
Investigating interventions in Alzheimer's disease with computer simulation models.
description Progress in the development of therapeutic interventions to treat or slow the progression of Alzheimer's disease has been hampered by lack of efficacy and unforeseen side effects in human clinical trials. This setback highlights the need for new approaches for pre-clinical testing of possible interventions. Systems modelling is becoming increasingly recognised as a valuable tool for investigating molecular and cellular mechanisms involved in ageing and age-related diseases. However, there is still a lack of awareness of modelling approaches in many areas of biomedical research. We previously developed a stochastic computer model to examine some of the key pathways involved in the aggregation of amyloid-beta (Aβ) and the micro-tubular binding protein tau. Here we show how we extended this model to include the main processes involved in passive and active immunisation against Aβ and then demonstrate the effects of this intervention on soluble Aβ, plaques, phosphorylated tau and tangles. The model predicts that immunisation leads to clearance of plaques but only results in small reductions in levels of soluble Aβ, phosphorylated tau and tangles. The behaviour of this model is supported by neuropathological observations in Alzheimer patients immunised against Aβ. Since, soluble Aβ, phosphorylated tau and tangles more closely correlate with cognitive decline than plaques, our model suggests that immunotherapy against Aβ may not be effective unless it is performed very early in the disease process or combined with other therapies.
format article
author Carole J Proctor
Delphine Boche
Douglas A Gray
James A R Nicoll
author_facet Carole J Proctor
Delphine Boche
Douglas A Gray
James A R Nicoll
author_sort Carole J Proctor
title Investigating interventions in Alzheimer's disease with computer simulation models.
title_short Investigating interventions in Alzheimer's disease with computer simulation models.
title_full Investigating interventions in Alzheimer's disease with computer simulation models.
title_fullStr Investigating interventions in Alzheimer's disease with computer simulation models.
title_full_unstemmed Investigating interventions in Alzheimer's disease with computer simulation models.
title_sort investigating interventions in alzheimer's disease with computer simulation models.
publisher Public Library of Science (PLoS)
publishDate 2013
url https://doaj.org/article/8caadb27d5ab41cb97fdeff47d23c4c2
work_keys_str_mv AT carolejproctor investigatinginterventionsinalzheimersdiseasewithcomputersimulationmodels
AT delphineboche investigatinginterventionsinalzheimersdiseasewithcomputersimulationmodels
AT douglasagray investigatinginterventionsinalzheimersdiseasewithcomputersimulationmodels
AT jamesarnicoll investigatinginterventionsinalzheimersdiseasewithcomputersimulationmodels
_version_ 1718421153538637824